)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tecan Group
Tecan Group (TECN) investor relations material
Tecan Group Morgan Stanley 24th Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Morgan Stanley 24th Annual Global Healthcare Conference summary14 Sep, 2026
Strategic positioning and transformation
Holds a leadership position in laboratory automation, especially liquid handling, with strong brand recognition and customer relationships.
Launched the Rewired transformation program to future-proof operations and consistently outperform market trends.
Focuses on attractive growth markets, leveraging AI and automation as essential tools for customers.
CEO brings over 25 years of industry experience and emphasizes leveraging company strengths for growth.
AI partnerships and digital innovation
Formed two distinct AI partnerships in 2026: with NVIDIA to enhance Introspect tool using agentic AI, and with Anthropic to support the Model Hardware Standard (MHS) for lab automation.
NVIDIA partnership enables predictive monitoring and smarter fleet management for lab instruments.
Anthropic collaboration aims to standardize communication between lab instruments and AI, accelerating the path to autonomous labs.
Considering new commercial models, including potential software subscriptions for AI-enabled features.
Market trends and business performance
Biopharma segment shows strong recovery with high single-digit growth, especially in instruments.
Diagnostics grew mid-single digits, supported by both life sciences and partnering segments.
Academic and government markets remain weak, with double-digit declines and cautious customer spending.
Asia, particularly Japan, Korea, and Australia, was a key growth driver in the first half of 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tecan Group
- Sales up 3.4% in local currencies, EBITDA margin 15.1%, and 2028 targets reaffirmed.TECN
H1 2026 - Q1 2026 delivered 3.4% sales growth and confirmed guidance, driven by Biopharma and Medtech.TECNQ1 2026 TU
- 2025 saw sales and profit decline, but transformation targets CHF 1bn sales and 20% EBITDA by 2028.TECNH2 2025
- Transformation, innovation, and automation drive renewed growth and market leadership.TECN44th Annual J.P. Morgan Healthcare Conference
- Sales growth resumed in H2 2025, with strong order entry and positive medium-term outlook.TECNH2 2025 TU
- Targets above-market growth via digital innovation, cost control, and global expansion.TECNCMD 2024
- Sales and profit fell on biopharma and China weakness, but order recovery signals future growth.TECNH1 2024
- Digital innovation and modular platforms drive growth despite 2024 headwinds.TECN43rd Annual J.P. Morgan Healthcare Conference 2025
- Sales and profit fell in 2024, but cost controls and innovation support a stable 2025 outlook.TECNH2 2024
Next Tecan Group earnings date
H2 202615 Mar, 2027
Tecan Group
Next Tecan Group earnings date
H2 202615 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Tecan Group AG is a Swiss company that provides laboratory instruments and automated solutions for the life sciences and diagnostics industries. The company designs and manufactures precision instruments used in biopharmaceutical research, clinical diagnostics, and forensic testing. Tecan’s product portfolio includes laboratory automation platforms, liquid handling systems, and detection devices, which help laboratories increase efficiency and throughput in processes such as drug discovery, genomics, and clinical diagnostics. The company is headquartered in Männedorf, Switzerland, and its shares are listed on the SIX.